Kathleen M Gura Selected Research

Parenteral Nutrition

3/2021	Current strategies for managing intestinal failure-associated liver disease.
1/2021	Prevention and Management of Parenteral Nutrition-Associated Cholestasis and Intestinal Failure-Associated Liver Disease in the Critically Ill Infant.
4/2020	ASPEN Consensus Recommendations for Refeeding Syndrome.
2/2020	Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.
1/2020	The Power of Networking and Lessons Learned From Omegaven.
1/2019	Fish oil-based injectable lipid emulsions containing medium-chain triglycerides or added α-tocopherol offer anti-inflammatory benefits in a murine model of parenteral nutrition-induced liver injury.
1/2019	Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.
1/2019	Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.
1/2018	Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease.
1/2018	Pediatric Intestinal Failure-Associated Liver Disease: Challenges in Identifying Clinically Relevant Biomarkers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen M Gura Research Topics

Disease

43	Liver Diseases (Liver Disease) 01/2022 - 07/2006
29	Intestinal Failure 01/2022 - 07/2006
24	Cholestasis 01/2021 - 07/2006
5	Infections 01/2022 - 05/2004
5	Inflammation (Inflammations) 11/2019 - 02/2011
5	Short Bowel Syndrome 11/2018 - 07/2006
5	Fibrosis (Cirrhosis) 02/2016 - 12/2006
4	Sepsis (Septicemia) 12/2020 - 07/2013
3	Hemorrhage 01/2022 - 01/2016
3	Critical Illness (Critically Ill) 01/2021 - 01/2010
3	Hypertriglyceridemia 01/2019 - 03/2008
3	Disease Progression 01/2018 - 01/2015
3	End Stage Liver Disease 02/2016 - 01/2015
3	Metabolic Bone Diseases (Osteopenia) 11/2015 - 09/2013
2	Weight Gain 01/2022 - 01/2017
2	Fatty Liver 01/2022 - 12/2006
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Necrosis 01/2019 - 01/2018
2	Cytomegalovirus Infections (Inclusion Disease) 01/2019 - 12/2011
2	Dyslipidemias (Dyslipidemia) 09/2011 - 09/2010
1	Body Weight (Weight, Body) 01/2022
1	Insulin Resistance 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Obesity 01/2022
1	Bronchopulmonary Dysplasia 01/2022
1	Confusion (Bewilderment) 02/2021
1	Refeeding Syndrome 04/2020
1	Endotoxemia 11/2019
1	Pruritus (Itching) 01/2019
1	Ischemia 01/2018
1	Reperfusion Injury 01/2018
1	Vitamin D Deficiency 10/2017
1	Tachypnea 01/2017
1	Lethargy 01/2017
1	Birth Weight (Birth Weights) 01/2016
1	Osteoporosis 11/2014
1	Dementia (Dementias) 11/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013
1	Hyperbilirubinemia 09/2010
1	Catheter-Related Infections 02/2010
1	Phlebitis 12/2009

Drug/Important Bio-Agent (IBA)

35	Fish OilsIBA 01/2022 - 07/2006
29	EmulsionsIBA 01/2022 - 03/2008
27	LipidsIBA 01/2022 - 08/2009
15	Soybean Oil FDA LinkGeneric 01/2022 - 09/2009
12	Intravenous Fat EmulsionsIBA 01/2021 - 10/2005
11	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 03/2008
7	BilirubinIBA 01/2021 - 03/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2011
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2011 - 08/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 02/2011
3	fish oil triglyceridesIBA 02/2020 - 06/2010
3	Triglycerides (Triacylglycerol)IBA 09/2011 - 12/2009
2	Phytosterols (Plant Sterols)IBA 01/2021 - 11/2013
2	Tocopherols (Tocopherol)IBA 01/2021 - 11/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 02/2010
2	Pharmaceutical PreparationsIBA 01/2020 - 08/2006
2	Essential Fatty AcidsIBA 01/2019 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Docosahexaenoic AcidsIBA 03/2017 - 08/2009
1	EnzymesIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Eicosapentaenoic AcidIBA 01/2022
1	VitaminsIBA 01/2022
1	Vitamin K FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Saline SolutionIBA 01/2018
1	IronIBA 10/2017
1	SeleniumIBA 10/2017
1	Trace Elements (Biometals)IBA 10/2017
1	MicronutrientsIBA 10/2017
1	ZincIBA 10/2017
1	Alkaline PhosphataseIBA 11/2015
1	AluminumIBA 11/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2013
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 09/2011
1	Arachidonic Acid (Vitamin F)IBA 09/2011
1	Ethanol (Ethyl Alcohol)IBA 02/2010
1	ElectrolytesIBA 02/2010
1	AlbuminsIBA 12/2009

Therapy/Procedure

40	Parenteral Nutrition 03/2021 - 10/2005
14	Therapeutics 01/2022 - 10/2005
5	Enteral Nutrition (Feeding, Tube) 04/2020 - 02/2010
4	Liver Transplantation 01/2021 - 07/2006
4	Catheters 01/2016 - 12/2009
3	Transplantation 01/2018 - 01/2015
2	Injections 02/2021 - 01/2017
2	Home Parenteral Nutrition 01/2021 - 11/2018
2	Central Venous Catheters 12/2020 - 05/2004
2	Total Parenteral Nutrition 09/2011 - 02/2011
1	Glycemic Control 01/2022
1	Nutritional Support (Artificial Feeding) 12/2020
1	Ketogenic Diet 11/2019
1	Nutrition Therapy (Medical Nutrition Therapy) 08/2018
1	Critical Care (Surgical Intensive Care) 10/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2016
1	Aftercare (After-Treatment) 01/2015